• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article (56661848)   Find a Category (125)   Find a Journal (7898)   Find a Contributing Scholar (3864)   Find an Academic Assistant (52)
Find an Article PDF (4834263)   Today's Articles (5723)
Citation(s) in RCA

Indexed Articles
Ranked By
Results Analysis
  •   
  •   
  •   
  •   
Results Analysis
Year Published
Show more   Refine
Article Type
Show more   Refine
Article Statistics
Refine
For: Rodrigues M, Eberst L, Follana P, Gauthier L, Jacquemin V, Tessier C, El Mouaddin N, Boudier P, Fiteni F, Angeli E, Roche S, Delanoy N, Sabatier R, Flippot R, de la Motte Rouge T. Real-world dostarlimab use in advanced/recurrent endometrial cancer in France. Bull Cancer 2023;110:1041-1050. [PMID: 37659907 DOI: 10.1016/j.bulcan.2023.06.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Accepted: 06/12/2023] [Indexed: 09/04/2023]
Number Cited by Other Article(s)
1
Raynaud C, Rodrigues M. [Dostarlimab plus chemotherapy for primary advanced or recurrent endometrial cancer]. Bull Cancer 2024;111:433-434. [PMID: 38493028 DOI: 10.1016/j.bulcan.2024.01.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2024] [Accepted: 01/08/2024] [Indexed: 03/18/2024]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA